UCLA Researchers & Innovators
Industry & Investors
News & Events
About
Concierge
Search Results - irradiation
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Synthetic Lethality of IR with ABBV-155 in Glioblastoma (GBM) (UCLA Case No. 2021-232)
UCLA researchers in the Department of Molecular and Medical Pharmacology have discovered that
irradiation
therapy can be combined with an antibody drug conjugate to form a novel therapeutic strategy to treat and extend survival of glioblastoma patients. BACKGROUND: Glioblastoma (GBM) is a fast-growing and aggressive brain tumor. The National Brain...
Published: 8/28/2024
|
Inventor(s):
David Nathanson
Keywords(s):
Antibody-Drug Conjugate
,
Apoptosis
,
Brain cancer
,
Cancer
,
Glioblastoma
,
irradiation
Category(s):
Therapeutics > Oncology
Targeting the Intrinsic Apoptotic Machinery in Glioblastoma Multiforme (GBM) (UCLA Case No. 2020-446)
UCLA researchers in the Department of Molecular and Medical Pharmacology identified the mechanisms of apoptotic resistance in glioblastoma multiforme (GBM) and developed a novel therapy to treat GBM. BACKGROUND: Glioblastoma (GBM) is the most aggressive form of brain tumor. Therapeutic options for GBM are limited and suboptimal. Treatment usually...
Published: 2/16/2024
|
Inventor(s):
David Nathanson
Keywords(s):
anti-apoptotic inhibitor
,
Anti-apoptotic pathway
,
Apoptosis
,
Brain Tumor
,
Glioblastoma
,
irradiation
,
p53
,
temozolomide
Category(s):
Therapeutics > Oncology